News Headlines

  1. Ajinomoto Althea, Inc. Opens Manufacturing Suites In New High Potency And Antibody Drug Conjugate Commercial Facility

    Ajinomoto Althea, Inc. (“Althea”), a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it will soon open a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility located in San Diego, CA. Althea took ownership of the new facility on May 1st, 2015 and phased construction and retrofitting commenced in January 2016.

  2. Brammer Bio Completes Expansion Of Cell And Gene Therapy Clinical Manufacturing Facilities In Florida

    Brammer Bio ("Brammer"), a cell and gene therapy contract development and manufacturing organization (CDMO), today announced completion of its clinical capacity expansion in Alachua, Florida.

  3. Emergent BioSolutions Awarded $63M BARDA Contract To Develop Treatment For Cyanide Exposure

    Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development Authority (BARDA) to develop an antidote spray device for the treatment of known or suspected acute cyanide poisoning.

  4. Recipharm And Kancera Collaborate To Manufacture Clinical Trial Supply

    Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567.

  5. Kaneka Eurogentec Announces The Construction Of A New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility

    Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced recently that its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter.

  6. Recipharm And CTC Launch Integrated First In Human Service

    Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones.

  7. Ardena Launches Following Pharmavize And Crystallics Merger

    A new early-phase contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics.

  8. Catalent To Acquire Cook Pharmica For $950M

    Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced it has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services.

  9. Life Science Leader And Clinical Leader Announce Clinical Leader Forum Date For 2018

    Life Science Leader and Clinical Leader ( are excited to announce that Clinical Leader Forum will return to Philadelphia. The event is scheduled for May 9-10, 2018 at the Hilton Philadelphia City Avenue.

  10. Research Reveals Costly Implementation Is The Biggest Barrier To Serialization Compliance

    According to new industry research more than half (54%) of industry professionals believe that the cost of implementing serialization is the greatest hurdle to compliance.